The FDA is planning some new research on DTC ads?highlighting?the price of the drug. The vast majority of DTC ads do not?currently?state price of the drug?or compare price to competitors. Some ads, which use price support, will tell consumers they get a rebate or coupon.?Some show a price the consumer will pay with the price […]
Tag Archives | fda
By Bob Ehrlich
April 8, 2014
Obesity Category May Heat Up
I saw some buzz from a financial site that Belviq, the newest Obesity drug, may start DTC television very soon. A Bank of America analyst was critical of Vivus for not doing DTC on Qsymia. The first drug to be approved for obesity in years took a very conservative approach to their launch and has […]
By Bob Ehrlich
March 17, 2014
DTC in Perspective: An Rx to OTC Mega Brand
The widespread stories about Pfizer trying to take Lipitor OTC bring up some important issues for drug companies trying to extend their statin brands to retail shelves. First, there is the concern about taking the doctor out of the direct decision chain to prescribe a drug for cholesterol reduction. Second, will consumers be able to […]
By Bob Ehrlich
February 26, 2014
FDA to Study Reducing Risk Disclosure on TV
Less is more goes the common saying. FDA, announced 2/18 in the Federal Register, that they are going to study having less risks read in TV ads. Their hypothesis is the litany of risks and warnings make it harder for the consumer to remember the most important ones. I have advocated, as have many advertising […]
By Bob Ehrlich
February 10, 2014
DTC in Perspective: FDA Does its Own DTC
The FDA is getting into the DTC business with an effort to stop teens from smoking. The campaign, starting February 11, is an attempt to stop teens from smoking by discussing the harm it does to things teens care about. While teens probably do not think about lung cancer or heart attacks they do care […]
By Bob Ehrlich
January 23, 2014
FDA Draft Guidance on Social Media
The long awaited?FDA draft guidance on social media?is probably not what many in the industry wanted. It does not make doing social media easier or provide more options to creatively use new media. It essentially is a guide to what content a drug company is responsible for and when it is not responsible. It is […]
